Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial

NCT07021534 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang University

Collaborators